David Tordrup

1.1k total citations
27 papers, 619 citations indexed

About

David Tordrup is a scholar working on Economics and Econometrics, Infectious Diseases and Molecular Biology. According to data from OpenAlex, David Tordrup has authored 27 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 5 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in David Tordrup's work include Health Systems, Economic Evaluations, Quality of Life (12 papers), Pharmaceutical Economics and Policy (6 papers) and Healthcare Policy and Management (5 papers). David Tordrup is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (12 papers), Pharmaceutical Economics and Policy (6 papers) and Healthcare Policy and Management (5 papers). David Tordrup collaborates with scholars based in United Kingdom, Netherlands and United States. David Tordrup's co-authors include Panos Kanavos, Aris Angelis, Jean Mossman, Félicie F. Andersen, Birgitta R. Knudsen, Zaheer‐Ud‐Din Babar, Aliya Naheed, Wu Zeng, Shyfuddin Ahmed and Alessandro Desideri and has published in prestigious journals such as ACS Nano, Vaccine and BMC Health Services Research.

In The Last Decade

David Tordrup

25 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Tordrup United Kingdom 12 178 128 87 85 69 27 619
Abdul Wahab Indonesia 16 19 0.1× 45 0.4× 89 1.0× 49 0.6× 52 0.8× 85 636
Asiye Uğraş Dikmen Türkiye 12 29 0.2× 68 0.5× 28 0.3× 25 0.3× 45 0.7× 62 490
Di Jiang China 13 50 0.3× 186 1.5× 92 1.1× 10 0.1× 52 0.8× 24 683
Adrian Marinovich United States 7 166 0.9× 83 0.6× 114 1.3× 12 0.1× 177 2.6× 10 615
Deborah Greenberg United States 10 24 0.1× 159 1.2× 54 0.6× 100 1.2× 62 0.9× 15 864
Chi Nguyen United States 14 24 0.1× 99 0.8× 269 3.1× 14 0.2× 168 2.4× 24 773
Anne Marie Murphy United States 13 29 0.2× 91 0.7× 31 0.4× 37 0.4× 81 1.2× 43 429
Dubhfeasa Slattery Ireland 14 25 0.1× 151 1.2× 85 1.0× 89 1.0× 95 1.4× 34 950
Edel McDermott Ireland 13 20 0.1× 77 0.6× 139 1.6× 214 2.5× 42 0.6× 16 479
Salma K. Marani United States 20 16 0.1× 100 0.8× 47 0.5× 223 2.6× 130 1.9× 32 902

Countries citing papers authored by David Tordrup

Since Specialization
Citations

This map shows the geographic impact of David Tordrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tordrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tordrup more than expected).

Fields of papers citing papers by David Tordrup

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Tordrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tordrup. The network helps show where David Tordrup may publish in the future.

Co-authorship network of co-authors of David Tordrup

This figure shows the co-authorship network connecting the top 25 collaborators of David Tordrup. A scholar is included among the top collaborators of David Tordrup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Tordrup. David Tordrup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tordrup, David, et al.. (2023). A systematic review of policies regulating or removing mark-ups in the pharmaceutical supply and distribution chain. Health Policy. 138. 104919–104919. 3 indexed citations
3.
Tordrup, David, Robert Smith, Kaloyan Kamenov, et al.. (2022). Global return on investment and cost-effectiveness of WHO's HEAR interventions for hearing loss : a modelling study. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 20 indexed citations
4.
Tordrup, David, et al.. (2022). Evidence on the effectiveness of policies promoting price transparency - A systematic review. Health Policy. 134. 104681–104681. 10 indexed citations
5.
Tordrup, David, Nathan Green, Max Petzold, et al.. (2022). Economic burden of female genital mutilation in 27 high-prevalence countries. BMJ Global Health. 7(2). e004512–e004512. 16 indexed citations
6.
Tordrup, David, et al.. (2022). A critical review of methodologies used in pharmaceutical pricing policy analyses. Health Policy. 134. 104576–104576. 3 indexed citations
7.
8.
Tordrup, David, Yvan Hutin, Karin Stenberg, et al.. (2020). Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income. Value in Health. 23(12). 1552–1560. 13 indexed citations
9.
Tordrup, David, Hendrika A. van den Ham, Julie Glanville, & Aukje K. Mantel‐Teeuwisse. (2020). Systematic reviews of ten pharmaceutical pricing policies – a research protocol. Journal of Pharmaceutical Policy and Practice. 13(1). 22–22. 9 indexed citations
10.
Tordrup, David, et al.. (2019). Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology. BMC Health Services Research. 19(1). 383–383. 46 indexed citations
11.
Tordrup, David, Yvan Hutin, Karin Stenberg, et al.. (2019). Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016–30. The Lancet Global Health. 7(9). e1180–e1188. 57 indexed citations
12.
Tordrup, David, C. Chouaïd, Pim Cuijpers, et al.. (2017). PRIORITIES FOR HEALTH ECONOMIC METHODOLOGICAL RESEARCH: RESULTS OF AN EXPERT CONSULTATION. International Journal of Technology Assessment in Health Care. 33(6). 609–619. 6 indexed citations
13.
Karyotaki, Eirini, David Tordrup, Claudia Buntrock, Roberto Bertollini, & Pim Cuijpers. (2016). Economic evidence for the clinical management of major depressive disorder: a systematic review and quality appraisal of economic evaluations alongside randomised controlled trials. Epidemiology and Psychiatric Sciences. 26(5). 501–516. 18 indexed citations
14.
Angelis, Aris, David Tordrup, & Panos Kanavos. (2016). Is the Funding of Public National Health Systems Sustainable over the Long Term? Evidence from Eight OECD Countries. Global Policy. 8(S2). 7–22. 7 indexed citations
15.
Dongen, Johanna M. van, et al.. (2016). Health economic evidence gaps and methodological constraints in low back pain and neck pain: Results of the Research Agenda for Health Economic Evaluation (RAHEE) project. Best Practice & Research Clinical Rheumatology. 30(6). 981–993. 16 indexed citations
16.
Angelis, Aris, David Tordrup, & Panos Kanavos. (2014). Socio-economic burden of rare diseases: A systematic review of cost of illness evidence. Health Policy. 119(7). 964–979. 202 indexed citations
17.
Tordrup, David, Jean Mossman, & Panos Kanavos. (2014). RESPONSIVENESS OF THE EQ-5D TO CLINICAL CHANGE: IS THE PATIENT EXPERIENCE ADEQUATELY REPRESENTED?. International Journal of Technology Assessment in Health Care. 30(1). 10–19. 51 indexed citations
18.
Tordrup, David, Aris Angelis, & Panos Kanavos. (2013). Preferences on Policy Options for Ensuring the Financial Sustainability of Health Care Services in the Future: Results of a Stakeholder Survey. Applied Health Economics and Health Policy. 11(6). 639–652. 11 indexed citations
19.
Roy, Amit, Ilda D’Annessa, David Tordrup, et al.. (2011). Peptide Inhibition of Topoisomerase IB fromPlasmodium falciparum. PubMed. 2011. 1–10. 11 indexed citations
20.
Tordrup, David, et al.. (2011). Variant Plasmodium ovale isolated from a patient infected in Ghana. Malaria Journal. 10(1). 15–15. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdul Wahab Breakdown of academic impact, for papers by Asiye Uğraş Dikmen Breakdown of academic impact, for papers by Di Jiang Breakdown of academic impact, for papers by Adrian Marinovich Breakdown of academic impact, for papers by Deborah Greenberg Breakdown of academic impact, for papers by Chi Nguyen Breakdown of academic impact, for papers by Anne Marie Murphy Breakdown of academic impact, for papers by Dubhfeasa Slattery Breakdown of academic impact, for papers by Edel McDermott Breakdown of academic impact, for papers by Salma K. Marani
Rankless by CCL
2026